MAPK3 and breast carcinoma: Chen and co-workers reported that a neutralizing antibody against integrin αVβ3 significantly attenuated CTGF-mediated ERK1/2 activation and cellular migration in human breast cancer cells, indicating that the integrin αVβ3-ERK1/2 signaling pathway is crucial in mediating CTGF function [21].